WASHINGTON, D.C. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, today praised the recent updated guidance from the All India Institute of Medical Science (AIIMS) to include ivermectin in its guidelines for the treatment of COVID-19.
As COVID-19 cases in India continue to increase at an alarming rate this guidance is a welcome development for the country’s efforts to treat those in need. We encourage all medical authorities, hospitals, physicians and medical professionals in India to follow the latest guidance from AIIMS.
“We are grateful that the AIIMS has followed the science on ivermectin in creating the new guidelines,” said Pierre Kory, M.P.A., MD, president and chief medical officer of the FLCCC. “I expect that if implemented, we will begin to see a decline in cases as we have seen in other regions when there is widespread use of ivermectin.”
The new guidelines can be found on the AIIMS website here: https://covid.aiims.edu
###
More on: Advocacy | Agency Response | All India Institute of Medical Science | India | Press Release
